Quinoline derivatives as kinase inhibitors
US9029392B2 · kind B2 · utility
0Cited by
0References
40Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 2, 2011 |
| Grant date | May 12, 2015 |
| Priority date | — |
| Expiry date | Sep 2, 2031 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed are a series of quinoline and quinoxaline derivatives comprising a fluorinated ethyl side-chain, being selective inhibitors of PI3 kinase enzymes, are accordingly of benefit in medicine, for example in the treatment of inflammatory, autoimmune, cardiovascular, neurodegenerative, metabolic, oncological, nociceptive or ophthalmic conditions. The compounds are of general formula (I):
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.